bluebird bio, Inc. (BLUE): Price and Financial Metrics


bluebird bio, Inc. (BLUE)

Today's Latest Price: $98.04 USD

0.57 (0.58%)

Updated Jan 17 12:00am

Add BLUE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 322 in Biotech

See all "A" rated Strong Buy stocks

BLUE Stock Summary

  • bluebird bio Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 8.99% of US listed stocks.
  • BLUE's price/sales ratio is 96.17; that's higher than the P/S ratio of 97.74% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.23 for bluebird bio Inc; that's greater than it is for just 12.63% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to bluebird bio Inc are AKTS, TBPH, RARE, APTX, and CUE.
  • BLUE's SEC filings can be seen here. And to visit bluebird bio Inc's official web site, go to www.bluebirdbio.com.
BLUE Daily Price Range
BLUE 52-Week Price Range

BLUE Stock Price Chart More Charts


BLUE Price/Volume Stats

Current price $98.04 52-week high $163.43
Prev. close $97.47 52-week low $71.42
Day low $96.89 Volume 1,753,800
Day high $99.36 Avg. volume 1,034,242
50-day MA $84.27 Dividend yield N/A
200-day MA $109.72 Market Cap 5.42B

bluebird bio, Inc. (BLUE) Company Bio


Bluebird Bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies. The company was founded in 1992 and is based in Cambridge, Massachusetts.





BLUE Latest News Stream


Event/Time News Detail
Loading, please wait...

BLUE Latest Social Stream


Loading social stream, please wait...

View Full BLUE Social Stream

BLUE Price Returns

1-mo 9.12%
3-mo 11.76%
6-mo -31.79%
1-year -24.56%
3-year 49.91%
5-year 6.17%
YTD 11.73%
2019 -11.54%
2018 -44.30%
2017 188.65%
2016 -3.92%
2015 -29.98%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6332 seconds.